Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CDK12 Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic Lethality.
Tien JC, Chang Y, Zhang Y, Chou J, Cheng Y, Wang X, Yang J, Mannan R, Shah P, Wang XM, Todd AJ, Eyunni S, Cheng C, Rebernick RJ, Xiao L, Bao Y, Neiswender J, Brough R, Pettitt SJ, Cao X, Miner SJ, Zhou L, Wu YM, Labanca E, Wang Y, Parolia A, Cieslik M, Robinson DR, Wang Z, Feng FY, Lord CJ, Ding K, Chinnaiyan AM. Tien JC, et al. Among authors: pettitt sj. bioRxiv [Preprint]. 2024 Mar 21:2024.03.20.585990. doi: 10.1101/2024.03.20.585990. bioRxiv. 2024. PMID: 38562774 Free PMC article. Preprint.
Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency.
Bajrami I, Walker C, Krastev DB, Weekes D, Song F, Wicks AJ, Alexander J, Haider S, Brough R, Pettitt SJ, Tutt ANJ, Lord CJ. Bajrami I, et al. Among authors: pettitt sj. Commun Biol. 2021 Nov 8;4(1):1270. doi: 10.1038/s42003-021-02770-2. Commun Biol. 2021. PMID: 34750509 Free PMC article.
Resistance to DNA repair inhibitors in cancer.
Baxter JS, Zatreanu D, Pettitt SJ, Lord CJ. Baxter JS, et al. Among authors: pettitt sj. Mol Oncol. 2022 Nov;16(21):3811-3827. doi: 10.1002/1878-0261.13224. Epub 2022 Jun 5. Mol Oncol. 2022. PMID: 35567571 Free PMC article. Review.
Opinion: PARP inhibitors in cancer-what do we still need to know?
Wicks AJ, Krastev DB, Pettitt SJ, Tutt ANJ, Lord CJ. Wicks AJ, et al. Among authors: pettitt sj. Open Biol. 2022 Jul;12(7):220118. doi: 10.1098/rsob.220118. Epub 2022 Jul 27. Open Biol. 2022. PMID: 35892198 Free PMC article. Review.
Cancer-associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7.
Baxter JS, Brough R, Krastev DB, Song F, Sridhar S, Gulati A, Alexander J, Roumeliotis TI, Kozik Z, Choudhary JS, Haider S, Pettitt SJ, Tutt ANJ, Lord CJ. Baxter JS, et al. Among authors: pettitt sj. Mol Oncol. 2024 Feb;18(2):369-385. doi: 10.1002/1878-0261.13537. Epub 2023 Oct 22. Mol Oncol. 2024. PMID: 37866880 Free PMC article.
Complex synthetic lethality in cancer.
Ryan CJ, Devakumar LPS, Pettitt SJ, Lord CJ. Ryan CJ, et al. Among authors: pettitt sj. Nat Genet. 2023 Dec;55(12):2039-2048. doi: 10.1038/s41588-023-01557-x. Epub 2023 Nov 30. Nat Genet. 2023. PMID: 38036785 Review.
51 results